Journal article
Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19: The TOGETHER Randomized Platform Clinical Trial
Abstract
ABSTRACT Background Recent evidence indicates a potential therapeutic role of fluvoxamine for COVID-19. In the TOGETHER randomized platform clinical trial for acutely symptomatic patients with COVID-19, we assessed the efficacy of fluvoxamine vs. placebo in preventing either extended emergency room observation or hospitalization due to COVID-19. Herein, we report the preliminary findings. Methods This placebo-controlled, randomized, …
Authors
Reis G; dos Santos Moreira Silva EA; Silva DCM; Thabane L; Milagres AC; Ferreira TS; dos Santos CVQ; de Figueiredo Neto AD; Callegari ED; Savassi LCM
Journal
, , ,
Publisher
Cold Spring Harbor Laboratory
DOI
10.1101/2021.08.19.21262323